Pico Laser Treatment for Pigmented Lesions: A Complete Clinical Guide for Practitioners

2026-06-18

Summary
Pigmented lesions are skin conditions caused by abnormal pigment deposition resulting from congenital genetic defects, acquired environmental factors, or skin aging. These lesions present with diverse clinical manifestations, including freckles, lentigines, nevi, and café‑au‑lait spots.
For practitioners and clinic owners looking to expand their aesthetic service offerings, understanding how to properly set treatment parameters when using Pico lasers for different types of pigmented lesions is essential for achieving optimal clinical outcomes while minimizing adverse effects. This guide provides detailed, evidence‑based protocols for treating four common types of pigmented lesions with picosecond laser technology.

1. Pico Laser Technology: Mechanism of Action
Picosecond lasers are defined as lasers with output pulse widths in the picosecond range (typically 300–750 ps), also known as sub‑nanosecond lasers. Common wavelengths include 532nm, 730nm, 755nm, 785nm, and 1064nm.
Due to their extremely short pulse durations, picosecond lasers can achieve exceptionally high peak power instantaneously, generating a photoacoustic (photomechanical) effect on target chromophores. This effect pulverizes melanin particles into much smaller fragments compared to traditional Q‑switched nanosecond lasers, making them easier for macrophages and other phagocytic cells to clear, while producing a milder inflammatory response.
Key advantages of picosecond over Q‑switched nanosecond lasers include:

Superior clearance rates for pigmented lesions and tattoos
Fewer treatment sessions required
Lower risk of post‑inflammatory hyperpigmentation (PIH)
Broader applicability across Fitzpatrick skin types
Additional cosmetic benefits including improved skin texture and pore refinement

According to the Expert Consensus on the Clinical Application of Picosecond Lasers, picosecond lasers can be used to treat various epidermal and dermal pigmented lesions. The technology has ideal efficacy for freckles, solar lentigines, and nevus of Ota; is effective for café‑au‑lait spots and lentigines (though with some recurrence risk); and can serve as a treatment option for more challenging conditions.

2. Treatment Parameter Selection: Core Principles
Before examining specific lesion types, practitioners should understand several foundational principles that apply across all pigmented lesion treatments:
2.1 Wavelength Selection by Lesion Depth

Lesion Depth	Recommended Wavelengths	Mechanism
Epidermal (freckles, solar lentigines, café‑au‑lait spots)	532nm, 755nm	Shallow penetration targets superficial melanin
Mixed epidermal‑dermal (melasma, some nevi)	755nm, 1064nm	Moderate penetration addresses pigment at multiple depths
Dermal (nevus of Ota, Hori’s nevus)	755nm, 1064nm	Deep penetration reaches dermal melanocytes

2.2 Endpoint Reactions
The clinical endpoint varies by lesion type and treatment approach:

Epidermal lesions (freckles, lentigines): Mild white frosting (immediate whitening)
Dermal lesions (nevus of Ota): Moderate frost with no tissue splatter (higher energy) or erythema without petechiae (lower energy)
Melasma: Mild erythema (gentle, conservative approach)

2.3 Fitzpatrick Skin Type Considerations
Picosecond lasers can be used across a broader range of skin types than nanosecond lasers due to the reduced risk of hyper‑ or hypopigmentation associated with photoacoustic (vs. photothermal) effects. However, special considerations apply for skin of color (Fitzpatrick IV–VI):

Increased epidermal melanin content adds risk for pigmentary complications
Conservative settings (lower fluence, larger spot size) are recommended
Test patching is strongly advised
Treatment intervals should be extended to allow complete healing

3. Treatment Protocols by Lesion Type
3.1 Freckles (Ephélides)
Freckles are the most common epidermal pigmentation disorder encountered in clinical practice.
Wavelength Options:

532nm is commonly used for freckle treatment
755nm shows higher lesion clearance and satisfaction rates
730nm demonstrates excellent selectivity for pigment with minimal damage to the dermal‑epidermal junction

Recommended Parameters:

Device/Wavelength	Energy Density	Spot Size	Endpoint
755nm (Picosure)	4.07 J/cm²	2.5 mm	Immediate whitening
730nm (Picoway)	1.4–1.7 J/cm²	3 mm	Mild frosting
532nm (Picoway)	Determined by skin type & presentation	Variable	Mild frosting

Treatment Tips:

Best results in Fitzpatrick III–IV with clearly demarcated lesions
Patients with lighter lesions or concurrent melasma have higher PIH risk
One session may achieve significant clearance; 1–3 sessions typically recommended
Treatment interval: 4–6 weeks

3.2 Solar Lentigines (Age Spots, Sunspots)
Solar lentigines are benign lesions occurring on sun‑exposed areas, particularly the face and backs of hands, increasing with age.
Wavelength Options:

532nm targets superficial pigment effectively
755nm provides excellent clearance with low PIH risk
730nm and 785nm are also effective

Recommended Parameters:

Device/Wavelength	Energy Density	Spot Size	Endpoint
532nm	0.6–1.4 J/cm²	3–6 mm	Mild frosting
755nm	4.07 J/cm²	2.5–3 mm	Immediate whitening

Treatment Tips:

One or two sessions can completely remove benign, flat lesions
50% lesion clearance achieved after two treatments across Fitzpatrick II–V
Treatment interval: 4–6 weeks
Excellent prognosis with low recurrence when sun protection is maintained

3.3 Café‑au‑Lait Macules (CALMs)
Café‑au‑lait macules are pigmented lesions often referred to as “coffee with milk” due to their light brown coloration. They are present at birth, more commonly called birthmarks, and remain throughout life.
Epidemiology:

Present in approximately 5% of Caucasians and up to 15% of Americans of African descent at birth
Can be treated across Fitzpatrick skin types I–IV

Wavelength Options:

532nm: For lighter, more superficial lesions
755nm: Effective alternative
1064nm: For deeper lesions

Recommended Parameters:

Parameters should be based on skin type and lesion color
Endpoint: Mild white frosting

Treatment Tips:

Efficacy varies; some patients show significant improvement while others have higher recurrence rates
May require multiple sessions (1–6+)
Treatment interval: 4–8 weeks
Pediatric patients may respond differently than adults

3.4 Nevus of Ota (and Hori’s Nevus / Acquired Bilateral Nevus of Ota‑like Macules)
Nevus of Ota is a dermal melanocytic condition characterized by blue‑gray pigmentation in the distribution of the ophthalmic and maxillary branches of the trigeminal nerve. Hori’s nevus (ABNOM) is a relatively common skin disorder often misdiagnosed as melasma.
Wavelength Options:

755nm is highlighted for its efficacy in Hori’s nevus
1064nm provides deep penetration for dermal melanocytes
730nm is also effective for dermal pigmentation

Recommended Parameters:

Approach	Spot Size	Energy Density	Endpoint
High Energy	2.5–3 mm	2.83–4.07 J/cm²	Moderate frost, no tissue splatter
Low Energy	4.5–5 mm	1.02–1.26 J/cm²	Erythema, no petechiae

Treatment Tips:

Treatment interval: 3–6 months
Generally requires multiple sessions to achieve clearance
Pediatric patients (nevus of Ota) typically require fewer sessions to achieve clearance than adults
Picosecond alexandrite laser shows higher single‑session clearance rates than Q‑switched nanosecond lasers
Higher PIH risk in Hori’s nevus; extend treatment intervals accordingly
755nm picosecond laser is safe and effective for treating nevus of Ota in children

4. General Treatment Guidelines
4.1 Pre‑Treatment Assessment

Evaluate Fitzpatrick skin type
Assess lesion color, depth, and borders
Document with standardized photography
Review patient history for photosensitizing medications, melasma, and PIH history
Consider test patching for darker skin types or uncertain responses

4.2 During Treatment

Apply appropriate eye protection for patient and operator
Use dynamic cooling or contact cooling to protect epidermis
Observe endpoint reactions carefully
Avoid overlapping pulses excessively
For dermal lesions, consider using larger spot sizes to minimize epidermal heating

4.3 Post‑Treatment Care

Apply cooling or soothing agents immediately
Strict sun protection (SPF 50+) for at least 4–6 weeks
Avoid exfoliants and irritating skincare products for 1 week
Schedule follow‑up at 4–8 weeks to assess response
Monitor for PIH, especially in Fitzpatrick III–VI

4.4 Common Adverse Effects and Management

Adverse Effect	Prevention	Management
Post‑inflammatory hyperpigmentation (PIH)	Conservative parameters, test patching, sun avoidance	Topical tyrosinase inhibitors, sun protection, extended intervals
Erythema/edema	Proper cooling, appropriate fluence	Usually self‑limiting; resolves within hours to days
Hypopigmentation	Avoid overly aggressive treatment in darker skin	May be transient or permanent; prevention is key

5. Key Takeaways for Clinic Owners
5.1 Why Offer Pico Laser Pigment Treatments?

High demand: Pigmented lesions are among the most common patient concerns
Excellent outcomes: Picosecond lasers provide superior clearance with fewer sessions
Low adverse event profile: Reduced PIH risk compared to nanosecond lasers
Versatility: One platform treats epidermal, dermal, and mixed lesions
Recurring revenue: Multiple sessions required for optimal results

5.2 Equipment Considerations

Ensure your Pico laser platform offers multiple wavelengths (at minimum 532nm and 1064nm, ideally with 755nm and 730nm options)
Verify FDA 510(k) clearance or CE marking for pigmented lesion indications
Consider platforms with adjustable spot sizes and energy density ranges suitable for diverse lesion types
Integrated cooling systems are essential for patient comfort and safety

5.3 Treatment Pricing Reference

Lesion Type	Typical Sessions	Price Range (Per Session, USD)
Freckles	1–3	$200–400
Solar lentigines	1–2	$250–500
Café‑au‑lait macules	3–6+	$300–600
Nevus of Ota / Hori’s	5–10+	$400–800

References

Expert Consensus on the Clinical Application of Picosecond Lasers
Guideline for the Diagnosis and Treatment in Laser and Aesthetic Medicine (2024)
Treatment Guidelines for the PicoWay® Laser System in Skin of Color
Picosecond Laser Treatment for Tattoos and Benign Cutaneous Pigmented Lesions
Wavelength‑dependent threshold fluences for melanosome disruption (PubMed, 2024)
A Prospective, Split‑Face, Randomized Study Comparing Picosecond to Q‑Switched Nd:YAG Laser for Treatment of Epidermal and Dermal Pigmented Lesions in Asians

Previous ：Fractional CO2 Laser Machine: The Complete B2B Buyer‘s Guide for Clinics and Medspas in 2026

Next article：Back to list

More news